Prometheus Biosciences Alpha and Beta Analysis
| RXDXDelisted Stock | USD 199.92 0.24 0.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Prometheus Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Prometheus Biosciences over a specified time horizon. Remember, high Prometheus Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Prometheus Biosciences' market risk premium analysis include:
Beta (0.09) | Alpha 1.04 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Prometheus |
Prometheus Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Prometheus Biosciences market risk premium is the additional return an investor will receive from holding Prometheus Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Prometheus Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Prometheus Biosciences' performance over market.| α | 1.04 | β | -0.09 |
Prometheus Biosciences Fundamentals Vs Peers
Comparing Prometheus Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Prometheus Biosciences' direct or indirect competition across all of the common fundamentals between Prometheus Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Prometheus Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Prometheus Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Prometheus Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Prometheus Biosciences to competition |
| Fundamentals | Prometheus Biosciences | Peer Average |
| Return On Equity | -0.33 | -0.31 |
| Return On Asset | -0.2 | -0.14 |
| Operating Margin | (40.65) % | (5.51) % |
| Current Valuation | 4.39 B | 16.62 B |
| Shares Outstanding | 47.81 M | 571.82 M |
| Shares Owned By Insiders | 16.61 % | 10.09 % |
| Shares Owned By Institutions | 81.01 % | 39.21 % |
Prometheus Biosciences Opportunities
Prometheus Biosciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Why Madrigal Pharmaceuticals Stock Gained 20 percent This Week | 04/20/2023 |
2 | Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors - Marketscreener.com | 04/24/2023 |
3 | Ieq Capital LLC Sells off 35.3 percent of Holding in Prometheus ... - Best Stocks | 04/28/2023 |
4 | Prometheus Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates | 05/09/2023 |
5 | Prometheus Biosciences, Inc. is a Great Momentum Stock Should You Buy | 05/12/2023 |
6 | We Think Prometheus Biosciences Can Afford To Drive Business Growth | 05/17/2023 |
7 | PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sa... | 05/22/2023 |
8 | Exercise or conversion by Mark McKenna of 122528 shares of Prometheus Biosciences subject to Rule 16b-3 | 06/02/2023 |
9 | Boxer Capital LLC Boosts Stock Position in Prometheus Biosciences, Inc. | 06/13/2023 |
About Prometheus Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Prometheus or other delisted stocks. Alpha measures the amount that position in Prometheus Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Prometheus Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Prometheus Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prometheus Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Prometheus Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Prometheus Biosciences. Please utilize our Beneish M Score to check the likelihood of Prometheus Biosciences' management manipulating its earnings.
| 10th of August 2023 Upcoming Quarterly Report | View | |
| 8th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Prometheus Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |